joey, as I'm sure you noticed, there were a bunch
Post# of 1460
Posted On: 08/02/2016 3:25:21 PM
joey, as I'm sure you noticed, there were a bunch of pump and dump operations by a couple of the traders' gangs at lieHUB. I observed at least 4 where people would start posting excitedly, talk about how this stock was going to be 100/share in a year, and a bunch of other unrealistic BS. Then they were strangely silent when the stock ran up to a peak and fell dramatically (my assumption -- that was when they sold), then a few days or weeks later, they'd come back and pump again.
This chart shows the pumping operations pretty clearly. If I had a lot of time to waste I'd go back and find sample posts from each of those run-ups, but I imagine everyone reading THIS post probably saw it for themselves when it was happening
http://bigcharts.marketwatch.com/quickchart/q...amp;time=9
So it could be that there will not be any substantive news on the Alzheimer's trial for awhile and the stock will flatline or sag. BUT, and this is important:
don't forget that they could announce either:
commencement of animal studies on Parkinson's, using the Michael J. Fox Foundation grant;
or, developing the epilepsy drug which seemingly has been put on the back burner after the good preliminary animal test results.
Or, they could announce something like a deeper statistical analysis of the results on the Alz trial, or a partnership to expand the study, or ? ? ? ? ?
That's the problem with these small biotechs -- any kind of news can spike or tank them, and their news cycle is far less predictable than a big biotech.
This chart shows the pumping operations pretty clearly. If I had a lot of time to waste I'd go back and find sample posts from each of those run-ups, but I imagine everyone reading THIS post probably saw it for themselves when it was happening
http://bigcharts.marketwatch.com/quickchart/q...amp;time=9
So it could be that there will not be any substantive news on the Alzheimer's trial for awhile and the stock will flatline or sag. BUT, and this is important:
don't forget that they could announce either:
commencement of animal studies on Parkinson's, using the Michael J. Fox Foundation grant;
or, developing the epilepsy drug which seemingly has been put on the back burner after the good preliminary animal test results.
Or, they could announce something like a deeper statistical analysis of the results on the Alz trial, or a partnership to expand the study, or ? ? ? ? ?
That's the problem with these small biotechs -- any kind of news can spike or tank them, and their news cycle is far less predictable than a big biotech.
(0)
(0)